IGI LABS INC FDA Approval ANDA 072071

ANDA 072071

IGI LABS INC

FDA Drug Application

Application #072071

Application Sponsors

ANDA 072071IGI LABS INC

Marketing Status

Discontinued001

Application Products

001INJECTABLE;INJECTION10MG/ML0NALBUPHINE HYDROCHLORIDENALBUPHINE HYDROCHLORIDE

CDER Filings

IGI LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 72071
            [companyName] => IGI LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NALBUPHINE HYDROCHLORIDE","activeIngredients":"NALBUPHINE HYDROCHLORIDE","strength":"10MG\/ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NALBUPHINE HYDROCHLORIDE","submission":"NALBUPHINE HYDROCHLORIDE","actionType":"10MG\/ML","submissionClassification":"INJECTABLE;INJECTION","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.